What is DarioHealth Corp.'s (DRIO) StockRank?

MoatMap's StockRank for DarioHealth Corp. (DRIO) is 11/100, with a Strong Sell signal. This is a composite score combining Quality (27), Value (39), and Momentum (25) factor ranks across MoatMap's 20,000+ stock universe.

Does DarioHealth Corp. have an economic moat?

DarioHealth Corp. (DRIO) has a Quality factor score of 27/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is DarioHealth Corp. a buy, hold, or sell?

MoatMap's current signal for DarioHealth Corp. (DRIO) is Strong Sell, based on a StockRank of 11/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is DarioHealth Corp. in?

DarioHealth Corp. (DRIO) operates in the Healthcare sector, specifically the Health Information Services industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

DRIO

STRONG SELLREMOVE

DarioHealth Corp. · Healthcare · United States · $51M · Avg Vol: $49K/d

StockRank

P/E (TTM)

—

ROE

-59.9%

D/E

0.5x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

DarioHealth is a micro-cap digital health provider. It has a history of high cash burn, lack of profitability, and high customer acquisition costs, failing the Terry Smith and Warren Buffett lenses.

COMPANY DESCRIPTION

DarioHealth Corp. is a leading global digital therapeutics company that offers a user-centric, multi-chronic condition management platform covering diabetes, hypertension, and musculoskeletal health. The company's competitive advantage lies in its highly engaging, AI-driven software platform that integrates biometric devices with personalized coaching to drive behavioral change. DarioHealth operates as a prominent player in the digital health and enterprise wellness sectors.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	27.7M	20.4M	27.0M	22.4M	-6.8%
EPS	-8.94	-7.18	-3.22	-10.12	—
Shares	7.3M	7.3M	7.3M	6.9M	-5.6%
Debt	28.0M	29.5M	30.2M	31.7M	4.2%
Equity	80.0M	58.1M	72.0M	67.9M	-5.3%
Op CF	-47.8M	-30.4M	-38.6M	-25.9M	—
Inv CF	-0.6M	-0.5M	-8.9M	-4.3M	—
Fin CF	61.9M	18.3M	38.5M	24.3M	—

PRICE (1Y)-18.8%

SMA 50SMA 200

$6.34

RSI (14)

8.0

52W High

$17.74

From 52W High

0.4%

SCORE BREAKDOWN

Quality

ROIC

-38.3%18.0

ROE

-59.9%14.8

GP/Assets

11.8%29.2

Op. Margin

-130.9%15.7

FCF/Assets

-9.9%28.2

Piotroski

430.3

Int. Cover

-12.8x20.9

D/E Ratio

0.51x31.5

Current Ratio

3.07x54.2

Value

P/E (TTM)

—N/A

EV/EBITDA

-1.9x25.0

P/FCF

—N/A

P/B

0.7x91.5

P/S

2.1x66.4

Div Yield

—N/A

Momentum

52W High %

36%11.8

RS 6M

-59%21.5

SMA 50/200

0.73x6.8

EPS Rev 4W

0.0%49.2

EPS Rev 12W

—N/A

EPS Improve

+92%70.3

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$51M

P/E (Forward)

-9.0x

Gross Margin

61.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of DRIO are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
DRIO	DarioHealth Corp.(you)	$51M	11	STRONG SELL
HCAT	Health Catalyst, Inc.	$124M	24	SELL
DH	Definitive Healthcare Corp.	$80M	38	HOLD
CARL	Carlsmed, Inc.	$264M	18	STRONG SELL
LFMD	LifeMD, Inc.	$223M	30	SELL
EVH	Evolent Health, Inc.	$486M	32	SELL
SDGR	Schrödinger, Inc.	$1.1B	15	STRONG SELL
WEAV	Weave Communications, Inc.	$406M	39	HOLD
CTEV	Claritev Corporation	$491M	39	HOLD
PHR	Phreesia, Inc.	$564M	41	HOLD

Peer medians: ROE -22.7% · P/E 25.2x · Gross margin 44.3%

DarioHealth Corp. (DRIO) — Stock Score Summary

DarioHealth Corp. (DRIO) has a MoatMap StockRank of 11/100 based on Quality (27/100), Value (39/100), and Momentum (25/100) factor scores. The current signal is STRONG SELL. DarioHealth is a micro-cap digital health provider. It has a history of high cash burn, lack of profitability, and high customer acquisition costs, failing the Terry Smith and Warren Buffett lenses.

Key Financial Metrics

Price	$6.34
Market Cap	$51M
P/E (Forward)	-8.96
Price/Book	0.71
Return on Equity	-59.9%
Return on Invested Capital	-38.3%
Debt/Equity	51.00
Gross Margin	61.1%
Operating Margin	-130.9%
Revenue Growth	-17.3%
Free Cash Flow	$-11M

DarioHealth Corp. operates in the Health Information Services industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is DarioHealth Corp.’s (DRIO) StockRank?: MoatMap’s StockRank for DarioHealth Corp. (DRIO) is 11/100, with a Strong Sell signal. It is a composite of Quality (27), Value (39), and Momentum (25) factor ranks across MoatMap’s 20,000+ stock universe.
Does DarioHealth Corp. have an economic moat?: DarioHealth Corp. (DRIO) has a Quality factor score of 27/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is DarioHealth Corp. a buy, hold, or sell?: MoatMap’s current signal for DarioHealth Corp. (DRIO) is Strong Sell, based on a StockRank of 11/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is DarioHealth Corp. in?: DarioHealth Corp. (DRIO) operates in the Healthcare sector, specifically the Health Information Services industry (United States).